The original explanation for a lower risk of colon cancer in the presence of a diet high in plant foods was attributed to effects of fiber-and there are both human studies (1) and an extensive experimental literature to support this view. Nonetheless, the more interesting and consistent finding is that vegetable and fruit intake is associated with lower risk of most epithelial cancers (2). Colon cancer is among these cancers; the highest quantile of intake is usually associated with an approximate halving of risk (3).
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Less is established about the possible prevention of the precursor lesions-adenomatous polyps-by a diet high in plant foods or their constituents. There are, nonetheless, several papers that suggest that a greater intake of vegetables and fruit lowers risk of polyps (4) .
The paper of Tseng et al. (5) , the first in this issue of the Journal, presents some evidence of a reduced risk of adenomatous polyps in the presence of greater intakes of specific micronutrients. The most striking features of these findings are the sex differences. With the sole exception of the (unexpectedly) inverse association with dietary iron, all of the nutrients that suggest a reduced risk in women are unassociated in men and vice versa. With additional analysis, folate appears to be the most consistent predictor of lower risk in women (with no evidence of interaction with alcohol use); in men, the consistent findings are vitamin E and, perhaps, calcium. It is not clear whether these differences speak to real differences between the sexes in the dietary predictors of colon cancer (3, 6) or whether what is being observed are differences in where dietary measurement error occurs across the sexes. The markedly different p values for trend in tables 2 and 3 of the Tseng et al. article (5) , for what appear to be slopes of a similar order, are a consequence of differences between the sexes in the differences in distributions between cases and controls (M. Tseng, Department of Epidemiology, University of North Carolina at Chapel Hill, 1996, personal communication). Again, is this telh'ng us about sex differences or measurement error?
The paper by Witte et al. (7), the second in this issue, provides some additional data. The authors report two important findings in addition to supporting the general lowering of risk of adenomatous polyps with greater intakes of vegetables and fruit. First, they show that some specific plant foods and plant products such as grains, garlic, and tofu are also associated with lower risk. Second, and most usefully, they show that the lower risks are not explained, at least completely, by several candidate agents-fiber, folate, /3-carotene, and vitamin C, nutrients that were previously shown to be inversely associated with risk in this study (8) .
There are at least two interpretations of the second finding. The conservative one is that the relevant variables are too poorly measured for the association to become completely attenuated, even when the variables are on the same causal pathway. The other is to conclude that there are unmeasured constituents that also contribute to the lower risk. Given the number of phytochemicals that could explain the association with high intakes of plant foods (9, 10), prudence and good science suggest the latter. The inconsistency of the findings across studies could support either explanation. Should we interpret findings that are more consistent (e.g., folate) as indicating something closer to the causal pathway (11), or do we just measure it better?
Although the adenoma-carcinoma sequence is a well-established hypothesis with both strong clinicopathologic support and evidence of specific somatic genetic changes (12, 13), the part played by external exposures, especially dietary constituents, in increasing or decreasing the likelihood of neoplasia is not well understood at all. The fact that a diet high in plant foods is associated with lowered risk of both polyps and cancer suggests, minimally, that the relevant agents act early in the pathway and that they reduce the risk of polyps that are likely to progress to cancer. Similar or different agents may, of course, act late in the process as well. This differs from the impact of smoking on colon carcinogenesis wherein exposure appears to increase the risk of adenomatous polyps, but these polyps do not often progress to cancer, and smoking does not act late in the cancer process.
Vegetable and fruit intakes are measured with error. Food tables, at best, provide average values for specific nutrients, and the levels of many phytochemicals in many foods are not known. Because of these and other causes, there is a marked lack of precision in measuring specific micronutrients and phytochemicals. Because specific nutrients are then metabolized in a variety of ways (e.g., by P450 and phase II enzymes), doses delivered to any tissue will be determined by metabolic profiles that vary both across populations and, by organ site, within individuals.
These problems can be overcome partially by continuing to undertake food analysis, by increasing our understanding of error structures in dietary studies, and by improving our capacity to measure, more directly, tissue levels of the specific nutrients and phytochemicals of interest. At some point, perhaps, it will become possible to undertake the kind of analysis presented by Witte et al. (7) in studies of both precursor lesions and cancer and to conclude, with confidence, which dietary constituents play what roles in explaining the protective effects of plant foods at various stages of carcinogenesis.
In the meantime, two hypotheses are worth entertaining. First, if we are able to identify specific protective constituents, these not only will vary with the stage of the cancer process, but they also will differ by sex and age and across genetic metabolic profiles; they will certainly vary, more generally, by organ site. Second, there will be very few magic bullets. Therefore, formulating pills to match a risk that is defined as [cancer site by sex by metabolic profile by ... and so forth] will be much more problematic than encouraging a general increase in the consumption of plant foods. This is a step we can take right now and enjoy the built-in redundancy of multiple agents with independent, overlapping, and perhaps interactive mechanisms. Besides, well-prepared food tastes better.
